| abstract |
The invention relates to phenyl- [1,2,4] -oxadiazol-5-one derivatives with a phenyl group in all stereoisomeric forms and mixtures thereof in any proportion as well as their body salts and tautomers their forms which exhibit PPAR-like racing activity. In particular, the compounds of formula (I) are described, in which the radicals are as defined and their salts accepted by the body and the processes for their preparation. The compounds are suitable for the treatment and / or prevention of disorders of fatty acid metabolism and disorders of glucose utilization as well as disorders involving insulin resistance and demyelinating and other neurodegenerative disorders of the central and peripheral nervous system. |